GL1X · GenesisL1 explorer

MolNFT v1 · #136250 · protein

Frizzled-8 complex with designed surrogate wnt agonist, crystal form 1

5UN5: “Frizzled-8 complex with designed surrogate wnt agonist, crystal form 1”. X-ray diffraction, 4 pockets (best druggability 0.38). MolNFT v1 #136250 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5UN5
Type
protein
Length
417 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Frizzled-8; Designed wnt agonist B12
UniProt
Q9H461
Pockets
4 · best druggability 0.38

Structure

x-ray diffraction · 3 distinct chains · 70% helix, 2% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
B, AFrizzled-8protein11944% helix, 6% strandQ9H461
DDesigned wnt agonist B12protein8889% helix, 0% strand—
CDesigned wnt agonist B12protein9187% helix, 0% strand—

Pockets

4 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1770.380.7717empty
2820.340.7416empty
3550.330.7814empty
4510.320.7712empty

Interfaces

3 interfaces between chains.

  • D–C · 2217 Ų buried · 10 hydrogen bonds · protein-protein
  • B–C · 787 Ų buried · 2 hydrogen bonds · protein-protein
  • A–D · 781 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 10 disulfide (disulfide).

Compared structures

  • 5UN5 · Frizzled-8 complex with designed surrogate Wnt agonist, crystal form 1 · the same entry in another collection · chain B against B, TM-score 1.00
  • Q9H461 · AlphaFold monomer V2.0 prediction for frizzled-8 (Q9H461) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.